RASSF1 and familial pancreatic carcinoma: CircHIPK3 overexpression was found to promote gemcitabine (GEM) resistance in pancreatic cancer cells by targeting “RASSF1” through miR-330-5p and was proposed to be a novel biomarker in GEM-resistant PC [154].